• Non ci sono risultati.

THURSDAY16 MAY 2019

N/A
N/A
Protected

Academic year: 2022

Condividi "THURSDAY16 MAY 2019"

Copied!
1
0
0

Testo completo

(1)

Università degli Studi di Torino Staff Formazione ECM Dott. Valentino Quarta

eventiecm.dam @unito.it 011-6709549

P. Black: Vancouver (Canada) M. Wirth: Dresden (Germany) A. Stenzl: Tübingen (Germany) H. Van Poppel: Leuven (Belgium) J. Palou: Barcelona (Spain) M. Gallucci: Rome (Italy)

M. Babjuk: Prague (Czech Republic) F. Witjes: Nijmegen (Netherlands) A. Breda: Barcelona (Spain)

ORGANIZING SECRETARIAT FACULTY

THURSDAY

16 MAY 2019

A.O.U. “Città della Salute e della Scienza di Torino” - Aula Magna “A.M. Dogliotti”

Corso Bramante, 88/90 - TORINO

STANDARD AND INNOVATIVE PROCEDURES FOR BLADDER CANCER IN 2019

Live Surgery Session

ECM - EACCME

7 credit ECM - cod. 173-249321

SCIENTIFIC COORDINATOR

Prof. Paolo Gontero

SCIENTIFIC SECRETARIAT

Dr. Francesco Soria Dr. Beatrice Lillaz

12:30 - 13:00 LIGHT LUNCH BUFFET 13:00 - 13:10 WELCOME

Stefano Carossa

(Director of Department of Surgical Sciences, University of Torino)

INTRODUCTION

Paolo Gontero

13:10 - 19:00 CASE PRESENTATION - Live Surgery session

Moderators in auditorium: Peter Black, Manfred Wirth, Paolo Gontero

ROOM A: Open Radical Cystectomy - step by step Urinary Diversion Arnulf Stenzl, Hein Van Poppel

ROOM B: Robotic Radical Cystectomy Intracorporeal diversion Joan Palou Redorta, Michele Gallucci

ROOM C:

Operation 1: “TURB: how should you do it”

Marek Babjuk

Operation 2: “TURB with PDD: how I do it”

Fred Witjes

Operation 3: “ Modern conservative treatment of UTUC:

from confocal laser endomicroscopy to laser ablation”

Alberto Breda

19:00 - 19:10 CONCLUSIONS & FAREWELL

Paolo Gontero

RATIONALE PROGRAM

The management of bladder cancer and upper tract urothelial carcinoma is continuously evolving due to the advent of new technologies and minimally invasive surgery.

The aim of the Meeting is to elucidate and debate the diagnostic, clinical and surgical management of complex uro- oncological cases, with a particular focus on urothelial cancers.

The conventional open surgery, as well as the minimally invasive and endoscopic approaches, will be performed during a fascinating Live Surgery session.

The therapeutic controversies and the “pro & cons” of these procedures will be interactively discussed in the plenary room thanks to the presence of international opinion leaders.

17-18 May 2019 Turin, Italy www.bca19.org

EAU onco-urology

series EAU Update on Bladder Cancer

SR FARMACEUTICI PHYSION

FARMITALIA

UNIVERSITÀ DEGLI STUDI DI TORINO

SPONSOR

Riferimenti

Documenti correlati

In the last 10 years the widespread acceptance of minimally invasive surgery for upper ab- dominal surgery has changed the surgical approach to this hernias, preferring

• Minimally invasive surgery has been an increasingly success in recent years and excellent results have been published in correlation with mitral valve surgery.

Results of Cryoablation for Atrial Fibrillation Concomitant With Video-Assisted Minimally Invasive Mitral Valve Surgery..

Muramaki M, Miyake H, Terakawa T, Kusuda Y, Fujisawa M (2011) Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with

Risteski et al., “Minimally invasive port access versus conventional mitral valve surgery: prospective randomized study,” Annals of Thoracic Surgery, vol.. Prince, “Mitral valve

Laparoscopic radical nephrectomy has a minimally invasive nature as well as long-term cancer control of patients with pT1–3a renal cell carcinoma compa- rable to open surgery.. It

The standard treatment for most patients with upper tract transitional cell carcinoma (TCC) is open com- plete nephroureterectomy (NU) with excision ofa cuff ofthe bladder and

Malignant tumors predominate, and the most important malignant neoplasms in this group are renal cell carcinoma, urothelial carcinoma of the urinary bladder, testicular carcinoma,